RA CAPITAL MANAGEMENT, L.P.

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$8.67B
Signature - Title
Rajeev Shah - Authorized Signatory
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by RA CAPITAL MANAGEMENT, L.P.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. RA CAPITAL MANAGEMENT, L.P. reported 81 stock holdings with total value $8.67B as of Q3 2024. Top holdings included ASND, PCVX, JANX, LEGN, and RYTM.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 81 $8.67B +$676M -$463M +$213M ASND, PCVX, JANX, LEGN, RYTM 13F-HR 11/14/2024, 04:33 PM
Q2 2024 78 $7.56B +$886M -$291M +$595M ASND, PCVX, JANX, LEGN, RYTM 13F-HR 8/14/2024, 04:13 PM
Q1 2024 1 $61.3M $0 $0 CGON New Holdings 5/17/2024, 04:30 PM
Q1 2024 76 $7.86B +$1.49B -$1.21B +$280M ASND, PCVX, LEGN, JANX, AVTE 13F-HR 5/15/2024, 05:20 PM
Q4 2023 62 $6.4B +$490M -$419M +$71M ASND, IMGN, PCVX, LEGN, RYTM 13F-HR 2/14/2024, 05:01 PM
Q3 2023 1 $37.6M $0 $0 CTKB New Holdings 11/15/2023, 08:08 AM
Q3 2023 66 $5.08B +$736M -$473M +$263M ASND, LEGN, PCVX, IMGN, ETNB 13F-HR 11/14/2023, 05:00 PM
Q2 2023 54 $5.3B +$899M -$620M +$279M ASND, LEGN, PCVX, DICE, ETNB 13F-HR 8/14/2023, 04:30 PM
Q1 2023 59 $4.42B +$475M -$256M +$219M ASND, PCVX, DICE, ETNB, AVTE 13F-HR 5/15/2023, 04:15 PM
Q4 2022 70 $4.93B +$644M -$823M -$179M ASND, PCVX, AVTE, DICE, VRNA 13F-HR 2/14/2023, 04:48 PM
Q3 2022 81 $4.68B +$526M -$316M +$210M ASND, BIIB, CTKB, FMTX, DAWN 13F-HR 11/14/2022, 04:39 PM
Q2 2022 88 $3.75B +$396M -$453M -$57.3M ASND, BIIB, CTKB, AVTE, DAWN 13F-HR 8/15/2022, 05:22 PM
Q1 2022 96 $4.58B +$694M -$426M +$268M ASND, BIIB, AVTE, CTKB, ITOS 13F-HR 5/16/2022, 04:34 PM
Q4 2021 97 $5.67B +$469M -$314M +$155M ASND, NVAX, ITOS, TVTX, JANX 13F-HR 2/14/2022, 04:13 PM
Q3 2021 95 $7.22B +$1.85B -$668M +$1.18B ASND, NVAX, ELYM, IVVD, FMTX 13F-HR 11/15/2021, 04:36 PM
Q2 2021 92 $6.16B +$1.28B -$515M +$764M ASND, NVAX, FMTX, JANX, VOR 13F-HR 8/16/2021, 04:35 PM
Q1 2021 82 $6.56B +$1.29B -$1.38B -$82.6M ASND, NVAX, VOR, AVIR, FMTX 13F-HR 5/17/2021, 04:31 PM
Q4 2020 82 $7.11B +$1.63B -$749M +$880M ASND, TGTX, NVAX, NKTX, FMTX 13F-HR 2/16/2021, 04:32 PM
Q3 2020 70 $5.47B +$1.16B -$705M +$458M ASND, FMTX, CCXI, PCVX, TGTX 13F-HR 11/16/2020, 04:34 PM
Q2 2020 57 $5.09B +$1.69B -$539M +$1.15B ASND, FMTX, NVAX, CCXI, TGTX 13F-HR 8/14/2020, 04:23 PM
Q1 2020 48 $3.11B +$995M -$828M +$167M ASND, RARX, CCXI, ARVN, ZGNX 13F-HR 5/15/2020, 04:30 PM
Q4 2019 34 $3.3B +$774M -$143M +$632M THOR, ASND, RARX, ARVN, CCXI 13F-HR 2/14/2020, 04:37 PM
Q3 2019 32 $1.68B +$212M -$123M +$89.2M ASND, WVE, THOR, RARX, ZGNX 13F-HR 11/14/2019, 04:32 PM
Q2 2019 25 $1.73B +$185M -$477M -$292M ASND, WVE, ZGNX, RARX, THOR 13F-HR 8/14/2019, 04:30 PM
Q1 2019 29 $2.23B +$225M -$96.8M +$128M ASND, WVE, THOR, ZGNX, RARX 13F-HR 5/15/2019, 04:31 PM
Q4 2018 25 $1.62B +$374M -$215M +$158M WVE, ASND, THOR, ZGNX, BCRX 13F-HR 2/14/2019, 04:59 PM
Q3 2018 26 $1.87B +$234M -$96.8M +$138M WVE, ASND, SLDB, ECYT, ZGNX 13F-HR 11/14/2018, 04:30 PM
Q2 2018 27 $1.54B +$307M -$171M +$136M WVE, ASND, SLDB, ECYT, MNTA 13F-HR 8/14/2018, 04:35 PM
Q1 2018 31 $1.31B +$128M -$267M -$140M WVE, ASND, AVXS, MYOV, SAGE 13F-HR 5/15/2018, 04:15 PM
Q4 2017 27 $1.2B +$286M -$221M +$65.5M WVE, ASND, AVXS, SAGE, IFRX 13F-HR 2/14/2018, 04:55 PM
Q3 2017 27 $1.06B +$170M -$129M +$41.6M ASND, WVE, AVXS, BHVN, ACHN 13F-HR 11/14/2017, 04:34 PM
Q2 2017 22 $871M +$234M -$126M +$108M ASND, WVE, AVXS, ACHN, BHVN 13F-HR 8/14/2017, 04:39 PM
Q1 2017 24 $815M +$79.1M -$76.9M +$2.19M WVE, ASND, AVXS, ACHN, AQXP 13F-HR 5/15/2017, 04:36 PM
Q4 2016 1 $18.7M $0 $0 MYOV New Holdings 2/16/2017, 04:04 PM
Q4 2016 27 $706M +$106M -$279M -$173M WVE, ASND, AVXS, ACHN, AQXP Restatement 2/16/2017, 04:03 PM
Q3 2016 31 $966M +$118M -$75.4M +$42.5M WVE, ACHN, ASND, AVXS, AXGT 13F-HR 11/14/2016, 05:12 PM
Q2 2016 32 $722M +$21.8M -$120M -$98.1M WVE, ACHN, AXGT, AVXS, ACRS 13F-HR 8/15/2016, 04:31 PM
Q1 2016 42 $782M +$194M -$158M +$36.7M WVE, ACHN, AXGT, ACRS, NKTR 13F-HR 5/16/2016, 04:36 PM
Q4 2015 37 $1.01B +$290M -$129M +$162M ACHN, WVE, DYAX, AXGT, ACRS 13F-HR 2/16/2016, 04:39 PM
Q3 2015 47 $696M +$186M -$209M -$23.3M ACHN, AXGT, DYAX, COLL, TGTX 13F-HR 11/13/2015, 04:10 PM
Q2 2015 58 $928M +$314M -$351M -$37.6M AXGT, ACHN, DYAX, TGTX, RGLS 13F-HR 8/13/2015, 04:23 PM
Q1 2015 56 $913M +$224M -$160M +$64M ACHN, DYAX, BCRX, RGLS, DRNA Restatement 7/6/2015, 02:53 PM
Q4 2014 48 $767M +$218M -$230M -$12.3M BCRX, ACHN, RGLS, DYAX, TGTX 13F-HR 2/17/2015, 04:14 PM
Q3 2014 43 $622M +$213M -$310M -$97M DYAX, BCRX, ACHN, AVNR, SNSS 13F-HR 11/14/2014, 04:23 PM
Q2 2014 24 $706M +$54.1M -$398M -$344M ACHN, DYAX, ENTA, DRNA, SGMO 13F-HR 8/14/2014, 04:11 PM
Q1 2014 29 $973M +$281M -$60.5M +$220M SGMO, ACHN, DRNA, DYAX, TXMD 13F-HR 5/15/2014, 01:38 PM
Q4 2013 24 $648M $0 $0 ACHN, SGMO, TXMD, NVAX, OPHT 13F-HR 2/14/2014, 11:49 AM